Brain Health Devices

The brain health devices market was valued at US$ 9,070.5 million in 2018, and is projected to exhibit a CAGR of 7.7%, during the forecast period (2019-2026).

SEATTLE , WASHINGTON, UNITED STATES, January 6, 2022 /EINPresswire.com/ -- 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

The growth of the global brain health devices market is expected to continue in the near future, especially in the developed countries. Increased geriatric population and incidence of neurological disorders are some of the factors driving this market growth. Technological advancements are also contributing to the growth of the market. Despite the benefits, a major drawback to this technology is stringent government regulations.

The global brain health devices market was valued at US$ 9,070.5 million in 2018, and is projected to exhibit a CAGR of 7.7%, during the forecast period (2019-2026).

𝐓𝐨 𝐠𝐞𝐭 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 @ https://www.coherentmarketinsights.com/insight/request-sample/1095

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐃𝐫𝐢𝐯𝐞𝐫𝐬

Approval and launch of new products is expected to propel growth of the global brain health devices market over the forecast period. For instance, in January 2019, Vercise Primary Cell and Vercise Gevia DBS systems featuring the Vercise Cartesia Directional Lead were launched by Boston Scientific Corporation for the treatment of Parkinson's disease.

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

Major players operating in the global brain health devices market are focused on adopting merger and acquisition strategies to expand their product portfolio. For instance, in August 2015, Medtronic plc. acquired Medina Medical, developer of Medina Embolization Device, to expand its hemorrhagic stroke product offering.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬

Product recalls are expected to limit growth of the global brain health devices market. For instance, in 2018, Monteris Medical, Inc. received a product recall notice from U.S. Food and Drug Administration for its NeuroBlate System due to unintended heating which can result in brain damage and death.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

In the U.S., from 3 January 2020 to 5:51pm CET, 16 December 2021, there have been 49,833,416 confirmed cases of COVID-19 with 792,371 deaths, reported to WHO. As of 9 December 2021, a total of 465,812,616 vaccine doses have been administered. Emergence of Covid-19 has led to increase in prevalence of mental diseases such as depression, which in turn is expected to boost demand for brain health devices.

𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/1095

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬

Major players operating in the global brain health devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in June 2018, Next Gen RNS System, a type of brain-computer interface, was launched by NeuroPace, Inc. for the treatment of refractory epilepsy.

Asia Pacific is expected to witness significant growth in the global brain health devices market, owing to high prevalence of neurological diseases in the region. For instance, according to the study, ‘Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature’, published in December 2019, in BMC’s The Journal of Headache and Pain, the 1-year prevalence of migraine among adults ranged from 6.0% to 14.3%.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

Major players operating in the global brain health devices market include, Advanced Brain Monitoring, Inc., BrainScope Company, Inc., Bio-Signal Group Corp., Cadwell Industries, Inc. Compumedics Ltd., DePuy Synthes, Elekta, Electrical Geodesics, Inc., GE Healthcare, Medtronic plc, MEG International Services Ltd, Natus Medical, Inc., Neurowave Systems Inc., Nihon Kohden Corporation, and Philips Healthcare.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

Major players operating in the global brain health devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in March 2019, Health Canada approved NeuroCatch Platform from NeuroCatch Inc. The platform a rapid neuro-physiological brain function assessment system.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐥𝐚𝐭 𝟑𝟎% 𝐎𝐅𝐅

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/insight/buy-now/1095

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.